Abstract
Purpose
Papillary thyroid carcinoma (PTC), the most common malignant tumor of the thyroid, has been criticized as overtreated by some researchers in recent years. Active surveillance (AS) was first proposed at Kuma Hospital in 1993, and popularized in other institutes ever since. We provide a brief review of low-risk PTC active monitoring studies to date, and discuss the advantages of AS and limitations of existing studies.
Results
Most papillary thyroid microcarcinomas do not show significant growth or new lymph node metastasis in a 10-year AS period. Patients who undergo delayed surgery during AS generally have a good prognosis. Tumor progression correlates with age, calcification pattern, and Ki-67 positivity. Serum thyroid stimulating hormone concentration and pregnancy might also influence tumor progression in some studies.
Conclusion
Active surveillance for low-risk PTC has shown its safety and feasibility in certain populations. In the future, it is warranted to determine valuable tumor progression predictors and most suitable PTC patients for AS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahn HS, Kim HJ, Welch HG (2014) Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med 371(19):1765–1767. https://doi.org/10.1056/NEJMp1409841
Anuwong A, Sasanakietkul T, Jitpratoom P, Ketwong K, Kim HY, Dionigi G, Richmon JD (2018) Transoral endoscopic thyroidectomy vestibular approach (TOETVA): indications, techniques and results. Surg Endosc 32(1):456–465. https://doi.org/10.1007/s00464-017-5705-8 (Epub 17 Jul 2017)
Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE (2014) PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma. Thyroid 24(9):1369–1374. https://doi.org/10.1089/thy.2014.0067 (Epub 16 Jul 2014)
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492 (Epub 12 Sep 2018)
Brito JP, Moon JH, Zeuren R, Kong SH, Kim YG, Iñiguez-Ariza NM, Choi JY, Lee KE, Kim JH, Hargraves I, Bernet V, Montori VM, Park YJ, Tuttle RM (2018) Thyroid cancer treatment choice: a pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options. Thyroid 28(10):1325–1331. https://doi.org/10.1089/thy.2018.0105 (Epub 25 Jul 2018)
Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95(8):625–627. https://doi.org/10.1093/jnci/95.8.625
Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140(4):317–322. https://doi.org/10.1001/jamaoto.2014.1
Davies L, Ouellette M, Hunter M, Welch HG (2010) The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope 120(12):2446–2451. https://doi.org/10.1002/lary.21076
Dionigi G, Chai YJ, Tufano RP, Anuwong A, Kim HY (2018) Transoral endoscopic thyroidectomy via a vestibular approach: why and how? Endocrine 59(2):275–279. https://doi.org/10.1007/s12020-017-1451-x (Epub 16 Oct 2017)
Fukuoka O, Sugitani I, Ebina A, Toda K, Kawabata K, Yamada K (2016) Natural history of asymptomatic papillary thyroid microcarcinoma: time-dependent changes in calcification and vascularity during active surveillance. World J Surg 40(3):529–537. https://doi.org/10.1007/s00268-015-3349-1
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020
Hirokawa M, Kudo T, Ota H, Suzuki A, Miyauchi A (2016) Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance. Endocr J 63(9):805–810 (Epub 7 Jul 2016)
Ho A (2017) Active surveillance of papillary thyroid microcarcinoma. https://clinicaltrials.gov/ct2/show/NCT02609685. Accessed 22 May 2019
Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13(4):381–387
Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34(1):28–35. https://doi.org/10.1007/s00268-009-0303-0
Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A (2014) Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24(1):27–34. https://doi.org/10.1089/thy.2013.0367 (Epub 14 Nov 2013)
Ito Y, Miyauchi A, Kudo T, Ota H, Yoshioka K, Oda H, Sasai H, Nakayama A, Yabuta T, Masuoka H, Fukushima M, Higashiyama T, Kihara M, Kobayashi K, Miya A (2016) Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital. Thyroid 26(1):156–160. https://doi.org/10.1089/thy.2015.0393 (Epub 15 Dec 2015)
Ito Y, Miyauchi A, Kudo T, Oda H, Yamamoto M, Sasai H, Masuoka H, Fukushima M, Higashiyama T, Kihara M, Miya A (2018) Trends in the implementation of active surveillance for low-risk papillary thyroid microcarcinomas at Kuma Hospital: gradual increase and heterogeneity in the acceptance of this new management option. Thyroid 28(4):488–495. https://doi.org/10.1089/thy.2017.0448 (Epub 2 Apr 2018)
Jeon M, Lee YM, Sung TY, Han M, Shin YW, Kim WG, Kim TY, Chung KW, Shong Y, Kim WB (2019) Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy: a cross-sectional study. Thyroid. https://doi.org/10.1089/thy.2018.0711 (Epub ahead of print)
Kim HI, Jang HW, Ahn HS, Ahn S, Park SY, Oh YL, Hahn SY, Shin JH, Kim JH, Kim JS, Chung JH, Kim TH, Kim SW (2018) High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance. J Clin Endocrinol Metab 103(2):446–451. https://doi.org/10.1210/jc.2017-01775
Kwon H, Oh HS, Kim M, Park S, Jeon MJ, Kim WG, Kim WB, Shong YK, Song DE, Baek JH, Chung KW, Kim TY (2017) Active surveillance for patients with papillary thyroid microcarcinoma: a single center’s experience in Korea. J Clin Endocrinol Metab 102(6):1917–1925. https://doi.org/10.1210/jc.2016-4026
Lang B (2018) A trial comparing USG-HIFU vs AS in management of low-risk PTMC. https://clinicaltrials.gov/ct2/show/NCT03327636. Accessed 22 May 2019
Lee S, Ryu HR, Park JH, Kim KH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS (2011) Excellence in robotic thyroid surgery: a comparative study of robot-assisted versus conventional endoscopic thyroidectomy in papillary thyroid microcarcinoma patients. Ann Surg 253(6):1060–1066. https://doi.org/10.1097/SLA.0b013e3182138b54
Li J, Liu Y, Liu J, Qian L (2018) Ultrasound-guided percutaneous microwave ablation versus surgery for papillary thyroid microcarcinoma. Int J Hyperth 34(5):653–659. https://doi.org/10.1080/02656736.2018.1453092 (Epub 11 Apr 2018)
Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M (2013) Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20(4):603–610. https://doi.org/10.1530/ERC-13-0210
Liu C, Liu Z, Chen T, Zeng W, Guo Y, Huang T (2016) TERT promoter mutation and its association with clinicopathological features and prognosis of papillary thyroid cancer: a meta-analysis. Sci Rep 6:36990. https://doi.org/10.1038/srep36990
Miyauchi A, Ito Y, Oda H (2018a) Insights into the management of papillary microcarcinoma of the thyroid. Thyroid 28(1):23–31. https://doi.org/10.1089/thy.2017.0227 (Epub 22 Sep 2017)
Miyauchi A, Kudo T, Ito Y, Oda H, Sasai H, Higashiyama T, Fukushima M, Masuoka H, Kihara M, Miya A (2018b) Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance. Surgery 163(1):48–52. https://doi.org/10.1016/j.surg.2017.03.028 (Epub 2 Nov 2017)
Nakajo A, Arima H, Hirata M, Mizoguchi T, Kijima Y, Mori S, Ishigami S, Ueno S, Yoshinaka H, Natsugoe S (2013) Trans-oral video-assisted neck surgery (TOVANS). A new transoral technique of endoscopic thyroidectomy with gasless premandible approach. Surg Endosc 27(4):1105–1110. https://doi.org/10.1007/s00464-012-2588-6 (Epub 21 Nov 2012)
Oda H, Miyauchi A, Ito Y, Yoshioka K, Nakayama A, Sasai H, Masuoka H, Yabuta T, Fukushima M, Higashiyama T, Kihara M, Kobayashi K, Miya A (2016) Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid 26(1):150–155. https://doi.org/10.1089/thy.2015.0313 (Epub 5 Nov 2015)
Oda H, Miyauchi A, Ito Y, Sasai H, Masuoka H, Yabuta T, Fukushima M, Higashiyama T, Kihara M, Kobayashi K, Miya A (2017) Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid. Endocr J 64(1):59–64. https://doi.org/10.1507/endocrj.EJ16-0381 (Epub 22 Sep 2016)
Oh HS, Ha J, Kim HI, Kim TH, Kim WG, Lim DJ, Kim TY, Kim SW, Kim WB, Shong YK, Chung JH, Baek JH (2018) Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea. Thyroid 28(12):1587–1594. https://doi.org/10.1089/thy.2018.0263 (Epub 17 Oct 2018)
Papini E, Guglielmi R, Gharib H, Misischi I, Graziano F, Chianelli M, Crescenzi A, Bianchini A, Valle D, Bizzarri G (2011) Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid 21(8):917–920. https://doi.org/10.1089/thy.2010.0447 (Epub 19 May 2011)
Park Y (2016) Active surveillance on papillary thyroid microcarcinoma. https://clinicaltrials.gov/ct2/show/NCT02938702. Accessed 22 May 2019
Park KN, Jung CH, Mok JO, Kwak JJ, Lee SW (2016) Prospective comparative study of endoscopic via unilateral axillobreast approach versus open conventional total thyroidectomy in patients with papillary thyroid carcinoma. Surg Endosc 30(9):3797–3801. https://doi.org/10.1007/s00464-015-4676-x (Epub 10 Dec 2015)
Parker C (2004) Active surveillance: towards a new paradigm in the management of early prostate cancer. Lancet Oncol 5(2):101–106
Sakai T, Sugitani I, Ebina A, Fukuoka O, Toda K, Mitani H, Yamada K (2019) Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid 29(1):59–63. https://doi.org/10.1089/thy.2018.0462 (Epub 8 Jan 2019)
Sanabria A (2018) Active surveillance in thyroid microcarcinoma in a Latin-American cohort. JAMA Otolaryngol Head Neck Surg 144(10):947–948. https://doi.org/10.1001/jamaoto.2018.1663
Sawka AM (2017) Deciding on active surveillance or surgery for primary management of low risk papillary thyroid cancer (AS-PTC). https://clinicaltrials.gov/ct2/show/NCT03271892. Accessed 22 May 2019
Shindo H, Amino N, Ito Y, Kihara M, Kobayashi K, Miya A, Hirokawa M, Miyauchi A (2014) Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 24(5):840–844. https://doi.org/10.1089/thy.2013.0527 (Epub 6 Mar 2014)
Sobin LH (1990) Histological typing of thyroid tumours. Histopathology 16(5):513
Sugitani I, Fujimoto Y, Yamada K (2014) Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg 38(3):673–678
Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A (1998) RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4(2):287–294
Teng D, Sui G, Liu C, Wang Y, Xia Y, Wang H (2018) Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol 144(4):771–779. https://doi.org/10.1007/s00432-018-2607-7 (Epub 9 Feb 2018)
Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, Untch B, Ganly I, Shaha AR, Shah JP, Pace M, Li D, Bach A, Lin O, Whiting A, Ghossein R, Landa I, Sabra M, Boucai L, Fish S, Morris LGT (2017) Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg 143(10):1015–1020. https://doi.org/10.1001/jamaoto.2017.1442
Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D, Ladenson PW (2004) Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 89(6):2867–2872. https://doi.org/10.1210/jc.2003-032050
Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O’Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Tufano RP, Pai SI, Zeiger MA, Westra WH, Clark DP, Clifton-Bligh R, Sidransky D, Ladenson PW, Sykorova V (2013) Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309(14):1493–1501. https://doi.org/10.1001/jama.2013.3190
Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J (2014) BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 32(25):2718–2726. https://doi.org/10.1200/JCO.2014.55.5094 (Epub 14 Jul 2014)
Yokozawa T, Miyauchi A, Kuma K, Sugawara M (1995) Accurate and simple method of diagnosing thyroid nodules the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid 5(2):141–145
Yue W, Wang S, Yu S, Wang B (2014) Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperth 30(2):150–157. https://doi.org/10.3109/02656736.2014.885590
Zhang M, Luo Y, Zhang Y, Tang J (2016) Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid 26(11):1581–1587 (Epub 18 Aug 2016)
Zhou W, Jiang S, Zhan W, Zhou J, Xu S, Zhang L (2017) Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: preliminary results. Eur Radiol 27(7):2934–2940. https://doi.org/10.1007/s00330-016-4610-1 (Epub 16 Nov 2016)
Zou M, Baitei EY, Alzahrani AS, BinHumaid FS, Alkhafaji D, Al-Rijjal RA, Meyer BF, Shi Y (2014) Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid 24(8):1256–1266. https://doi.org/10.1089/thy.2013.0610 (Epub 10 Jun 2014)
Funding
This study was funded by the National Natural Science Foundation of China (81800752) and the Natural Science Foundation of Jiangsu Province (BK20170125).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ze, Y., Zhang, X., Shao, F. et al. Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence. J Cancer Res Clin Oncol 145, 2751–2759 (2019). https://doi.org/10.1007/s00432-019-03021-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-019-03021-y